Nephrogenex

Innovator developing drugs for kidney disease, particularly diabetic nephropathy

placeRaleigh, North Carolina, United States calendar_todayFounded 2004 groups6 employees language nephrogenex.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 134 times.

YearFilings
20122
20133
20142
20151
20162

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon